Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.142ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.523ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.523ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.418ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.418ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.389ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.389ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.53ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.53ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.363ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.363ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HV.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HV.1.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.401ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.401ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.362ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.362ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GK.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.216ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.216ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.471ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.471ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.16ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.420ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.420ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
L.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
L.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.561ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.561ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.605ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.605ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.596ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.596ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
W.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used